Drug · DIN 02490846
PLERIXAFOR INJECTION
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since August 2, 2022.
- Drug Identification Number (DIN)
- 02490846
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Plerixafor L03AX16
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PLERIXAFOR | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 2, 2022: NOC 28690Abbreviated New Drug Submission (ANDS)
Other DINs named PLERIXAFOR INJECTION
- DIN 02529815 · Marketed
- DIN 02539454 · Marketed